20
April
2016
|
00:00
Europe/Amsterdam

Notice of Preliminary Results

Leeds, 20th April 2016 - Tissue Regenix Group plc (AIM:TRX) ("Tissue Regenix" or "The Group"), the regenerative medical devices company, announces that it will publish its unaudited preliminary results for the year ended 31st January 2016, on Monday 23rd May 2016.

A results presentation will be held on the morning of the 23rd May in , with corporate and financial updates from CEO Antony Odell, and CFO, Ian Jefferson, as well as guest speaker Dr Francisco da Costa from The Groups research partner, Pontifícia Universidade Católica do , .

If you would like to attend, or for further information, please contact c.pearson@tissueregenix.com